<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02845076</url>
  </required_header>
  <id_info>
    <org_study_id>BaskentU</org_study_id>
    <nct_id>NCT02845076</nct_id>
  </id_info>
  <brief_title>Weaning From Noninvasive Ventilation</brief_title>
  <acronym>WEANIV</acronym>
  <official_title>Weaning From Noninvasive Ventilation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Baskent University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Bologna</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Marmara University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Istanbul Sureyyapasa Chest Diseases and Chest Surgery Training and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Dokuz Eylul University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Cukurova University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ospedale San Donato</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Azienda Ospedaliero Universitaria Maggiore della Carita</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Milan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Azienda Ospedaliera G. Rummo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital General Universitario Morales Meseguer</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Taichung Veterans General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Sao Joao</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ospedale Regionale Bellinzona e Valli</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Masih Daneshvari Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shahid Beheshti University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Pandit Bhagwat Dayal Sharma, PGIMS, Rohtak</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Baskent University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Noninvasive ventilation (NIV) weaning strategies differ considerably from one another. These
      strategies have yet not been compared to each other. Therefore, the investigators planned to
      perform a prospective, randomized, pilot study involving hypercapnic acute respiratory
      failure patients ready to be weaned off from NIV. The investigators are going to compare the
      success rate of NIV weaning and the duration of NIV after randomization between 3 NIV weaning
      methods: gradual decrease in duration of NIV or level of ventilator support, and abrupt
      discontinuation of NIV.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>August 2016</start_date>
  <completion_date type="Anticipated">June 2017</completion_date>
  <primary_completion_date type="Anticipated">April 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The comparison of total duration of NIV after randomization</measure>
    <time_frame>up to 10 days</time_frame>
    <description>The patients will be considered as 'weaning failure' if:
The participant will meet the NIV reinstitution or intubation criteria during the weaning phase or within the first 5 days of NIV discontinuation
Weaning from NIV was not possible If the failing patient stabilizes afterwards and passes the screening and weaning criteria, the patient will be weaned again with the same protocol. If the patient fails weaning trials 3 times, then the patient will not be re-considered for further enrollment.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of NIV re-institution</measure>
    <time_frame>10 days of NIV discontinuation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NIV weaning success rates</measure>
    <time_frame>10 days of NIV discontinuation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of ICU stay</measure>
    <time_frame>up to 24 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rates of intubation</measure>
    <time_frame>first 5 days of NIV discontinuation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>In-hospital mortality</measure>
    <time_frame>up to 24 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">141</enrollment>
  <condition>Hypercapnic Respiratory Failure</condition>
  <condition>Weaning Failure</condition>
  <condition>Noninvasive Ventilation</condition>
  <arm_group>
    <arm_group_label>Decrease in duration</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Weaning will be started with the liberation of patient from NIV during day-time and then nighttime support will be gradually reduced. From day 2 the daytime NIV will be gradually decreased in steps of at least 2 hours/day at the attending discretion. At day 2, nighttime discontinuation will be considered. When a patient reaches without the presence of any reinstitution criteria, the duration of NIV use as 4 hours per 16 hours during daytime, it will be liberated definitively from NIV.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Decrease in pressure and duration</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Weaning will be started with the liberation of patient from NIV during day-time and then nighttime support will be gradually reduced. The level of pressure support will be decreased by 2-4 cmH2O per 4 hours during daytime in patients with good tolerance, with no change at night time. From day 2 the daytime NIV will be gradually decreased in steps of at least 2 hours/day at the attending discretion. At day 2, nighttime discontinuation will be considered, based on the vitals and ABGs recorded at 8 pm (see above), with gradual decrease of at least 2 hrs/night. When a patient reaches without the presence of any reinstitution criteria, the level of PS of 8 cmH20, it will be liberated definitively from NIV.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Abrupt discontinuation of NIV</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will be disconnected from NIV and oxygenated with a nasal cannula. Oxygen flow will be limited to a maximum of 5L/min.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Protocol for weaning of noninvasive ventilation</intervention_name>
    <description>3 protocols for weaning of noninvasive ventilation will be compared</description>
    <arm_group_label>Decrease in duration</arm_group_label>
    <arm_group_label>Decrease in pressure and duration</arm_group_label>
    <arm_group_label>Abrupt discontinuation of NIV</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patients will be screened by the physician 24 hours (±6 hours) after initiation of NIV
        treatment if:

          -  Age ≥18 years old

          -  Hypercapnic ARF ( baseline pH&lt;7.35, paCO2&gt;45 mmHg, BORG&gt;4)

          -  Breathing frequency&lt; 25 bpm under NIV

          -  pH &gt;7.35 under NIV

          -  20% or more decrease from baseline PaCO2 under NIV

          -  Kelly ≤ 2 under NIV (Alert. Follows simple/3 step complex commands)

          -  PaO2 between 60 and 70 mmHg under NIV

          -  No need for sedation

          -  Systolic blood pressure 90-180 mmHg without vasopressors

          -  Body temperature 36-38°C

          -  Heart rate 50-120 bpm

        The patient will be enrolled to the study and will be randomized to one of the NIV weaning
        protocols, if passes daily weaning criteria listed below after 1 hour of spontaneous
        breathing (with supplementary oxygen),

          -  Respiratory rate 8-30 bpm

          -  Systolic blood pressure 90-180 mmHg without vasopressors

          -  Body temperature 36-38°C

          -  Heart rate 50-120 bpm

          -  Neurologic score of Kelly ≤2 (Alert. Follows simple/ 3-step complex commands),

          -  SaO2 ≥88-92% with a FiO2≤40%.

          -  pH≥7.35

          -  Absence of severe dyspnea (BORG&gt;4).

        Exclusion Criteria:

          -  Age &lt;18 years old

          -  NIV use at home for chronic respiratory failure

          -  CPAP use for acute respiratory failure

          -  NIV use as palliative treatment

          -  Severe heart failure with cardiac index ≤ 2 L/min/m2

          -  Severe hepatic failure with bilirubin ≥ 34.2µmol/L

          -  Severe renal failure with creatinine ≥ 220 µmol/L
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stefano Nava</last_name>
    <role>Study Chair</role>
    <affiliation>Bologna University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Begum Ergan</last_name>
    <role>Study Director</role>
    <affiliation>Dokuz Eylul University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sait Karakurt</last_name>
    <role>Principal Investigator</role>
    <affiliation>Marmara University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Zuhal Karakurt</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sureyyapasa Center for Chest Diseases and Thoracic Surgery Training and Investiagation Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ezgi Ozyılmaz</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cukurova University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Raffaele Scala</last_name>
    <role>Principal Investigator</role>
    <affiliation>San Donato Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Paolo Navalesi</last_name>
    <role>Principal Investigator</role>
    <affiliation>Maggiore della Carita Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Fabiano Di Marco</last_name>
    <role>Principal Investigator</role>
    <affiliation>Milan University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mario Del Donno</last_name>
    <role>Principal Investigator</role>
    <affiliation>&quot;G.Rummo&quot; Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Antonio Esquinas</last_name>
    <role>Principal Investigator</role>
    <affiliation>Morales-Mesguer Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ming Cheng-Chan</last_name>
    <role>Principal Investigator</role>
    <affiliation>Taichung Veterans General Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Filipe Conceicao</last_name>
    <role>Principal Investigator</role>
    <affiliation>São João Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Andreas Perren</last_name>
    <role>Principal Investigator</role>
    <affiliation>Regionale Bellinzona e Valli Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Seyed Mohammad</last_name>
    <role>Principal Investigator</role>
    <affiliation>Masih Daneshvari Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Atefeh Fakharian</last_name>
    <role>Principal Investigator</role>
    <affiliation>Shahid Beheshti University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Neetu Jain</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pt. Bhagwat Dayal Sharma, Postgraduate Institute of Medical Sciences</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Aylin Ozsancak Ugurlu, MD</last_name>
    <phone>905327425233</phone>
    <email>aozsancak@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Begum Ergan</last_name>
    <phone>905326327686</phone>
    <email>begumergan@gmail.com</email>
  </overall_contact_backup>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 28, 2016</study_first_submitted>
  <study_first_submitted_qc>July 22, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 27, 2016</study_first_posted>
  <last_update_submitted>July 22, 2016</last_update_submitted>
  <last_update_submitted_qc>July 22, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 27, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Baskent University</investigator_affiliation>
    <investigator_full_name>Aylin Ozsancak Ugurlu</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Noninvasive ventilation</keyword>
  <keyword>Respiratory insufficiency</keyword>
  <keyword>Hypercapnia</keyword>
  <keyword>ventilator weaning</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Insufficiency</mesh_term>
    <mesh_term>Hypercapnia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

